POSB369 development of the patient-reported impact of dermatological diseases (PRIDD) measure

Pattinson, R. ORCID: https://orcid.org/0000-0002-3145-3710, Trialonis-Suthakharan, N., Austin, J., Augustin, M. and Bundy, C. ORCID: https://orcid.org/0000-0002-5981-3984 2022. POSB369 development of the patient-reported impact of dermatological diseases (PRIDD) measure. Value in Health 25 (1) , S232. 10.1016/j.jval.2021.11.1136

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (113kB)

Abstract

Dermatological conditions are the fourth most common health condition worldwide and carry a physical, psychological and social burden for patients. The existing burden metrics in dermatology (e.g. patient-reported outcome measures [PROMs]) arguably underestimate the breadth of the impact of dermatological conditions on patients’ lives. The Global Research on the Impact of Dermatological Diseases (GRIDD) project is developing a new measure (Patient-Reported Impact of Dermatological Diseases - PRIDD) to better understand the true impact. GRIDD is the first global patient-initiated and -led impact research study in dermatology.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Healthcare Sciences
Publisher:	Elsevier
ISSN:	1098-3015
Date of First Compliant Deposit:	21 April 2022
Date of Acceptance:	19 August 2021
Last Modified:	21 Nov 2024 14:00
URI:	https://orca.cardiff.ac.uk/id/eprint/149252

Actions (repository staff only)

Edit Item